Amendment to Urinalysis Reagents and Consumables w/Leased Analyzer for Fort Sill, Oklahoma

The Department of the Army Medical Command is seeking a comprehensive urinalysis reagents and consumables contract with a leased analyzer for Reynolds Army Health Clinic at Fort Sill, Oklahoma. The solicitation (W81K0025QA069) requires a fully automated, discrete random access urine chemistry analyzer system with three key components: a urine chemistry analyzer, a urine particle analyzer, and a digital imaging analyzer. The system must interface with the Military Health System Genesis Laboratory Information System and perform multiple diagnostic tests including glucose, bilirubin, ketone, blood, pH, and protein levels. The procurement will use a Lowest Price Technically Acceptable (LPTA) source selection process, with all proposals due by June 6, 2025, at 10:00 a.m. Central Standard Time. Vendors must submit questions by May 14, 2025, and will receive answers around May 19, 2025, with the contract structured as a cost per patient reportable (CPPR) agreement.

The solicitation is not set aside for any specific small business designation, though the original solicitation referenced a Women-Owned Small Business (WOSB) preference. The contract includes a base year and four option years, with an annual requirement of 9,125 analyzers to be delivered and invoiced monthly. The contract is scheduled to begin on October 1, 2025, with analyzers to be delivered by August 1, 2025, for correlation and validation. Performance will occur at Fort Sill, Oklahoma 73503, with the contractor responsible for installation, scientific studies, training, supplies, reagents, maintenance, and equipment removal. The solicitation falls under NAICS Category 325413 for In-Vitro Diagnostic Substance Manufacturing and PSC Category 6550 for In Vitro Diagnostic Substances, Reagents, Test Kits and Sets, indicating a specialized medical diagnostics procurement.